Introduction
Cardiopulmonary bypass is a technique used to bypass the heart and lungs in order to facilitate heart surgery. It has been reported to be associated with hemostatic defect and activation of the inflammatory system. 1 The consequences of blood cell activation and plasma protein alteration during cardiopulmonary bypass prolong the bleeding time, increase the post-operative blood loss and necessity for massive infusion of blood lead to pulmonary function abnormality. 1, 2 Massive transfusion can cause not only transmission of infection and circulatory overload, but also increase the mortality risk, longer stay in Intensive Care Unit and hospital, and increase the mortality. 3, 4 Cardiopulmonary bypass activates large number of platelets, which then bind to exposed sub -endothelium, to the cardiopulmonary bypass circuit, or to circulating monocytes and neutrophils, potentially causing platelet numbers to decrease beyond what would be expected from hemodilution alone. [5] [6] [7] In addition to thrombocytopenia, a qualitative platelet defect during the cardiopulmonary bypass has also been reported. The combination of a decrease in platelet number and altered platelet function are responsible for a major proportion of blood loss associated with cardiopulmonary bypass. 8-
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Cardiopulmonary bypass has been reported to be associated with hemodilution in order to improve the oxygen delivery and tissue perfusion, and in a typical adult, the onset of cardiopulmonary bypass decreases the hematocrit from 40% to approximately 25%. 11 Additionally, fibrinogen is known to bind extra-corporeal surfaces within minutes when blood passage through the cardiopulmonary bypass circuit. This bounded fibrinogen is conformationally altered in such a way that it is capable of binding to the resting glycoprotein IIb/IIIa receptor on platelets, thus responsible for more decrease in the circulatory platelets and fibrinogen and post-cardiopulmonary bypass bleeding. 10, 11 It has been documented that the tissue factor path-way, the extrinsic pathway of coagulation is also activated during the cardiopulmonary bypass by surgical disruption of the endothelium.
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However, cardiopulmonary bypass-induced hemostatic defect during and after cardiac surgery is not conclusive and found that cardiopulmonary bypass assisted bypass surgery does not significantly alter hemostasis during and after operation compared to that of off-pump | Original | Article |
Abstract
This study aimed to evaluate the hemostatic derangement in patients undergoing elective cardiac surgery using cardiopulmonary bypass. Total 55 patients of either sex, were divided into three groups: Group A (n=20): Patients selected for elective cardiac surgery without cardiopulmonary bypass; Group B (n=20): Patients who undergone cardiac surgery with cardiopulmonary bypass time <90 min; and Group C (n=15): Patients who undergone cardiac surgery with cardiopulmonary bypass time either 90 min or more. The difference of mean hemoglobin, total count of WBC, and platelet count on immediate post-operative period and at 7 days after surgery were statistically significant among the groups. The mean hematocrit value, fibrinogen level and coagulation profile were statistically significant between the two groups in comparison to preoperative value. The mean cross-clamp time and bypass time were statistically significant between the two sub-groups of cardiopulmonary bypass population. The mean blood loss was more (1513.3 ± 307.9 mL) where the cardiopulmonary bypass was used for >90 min in comparison to other population. Prolong cardiopulmonary bypass time associated with more hemostatic abnormalities and complications can be minimized by shortening the bypass time. Therefore, the present study was designed to evaluate the association between the cardiopulmonary bypass and hemostatic defect in patient undergoing cardiac surgery and the after effect during peri-operative and post-operative period. The patient prepared for cardiac surgery either with cardiopulmonary bypass or without cardiopulmonary bypass and agree to participate was purposively selected for the present study. Informed written consent was taken in a prescribed form. After selection of patients and enrolment in the present study, the detailed history and clinical examination findings were recorded in the predesigned data collection sheet pre-operatively. Cardiopulmonary bypass time, aortic cross-clamp time, blood loss and blood transfusion were recorded in the pre-designed data collection sheet at the end of the operation and cardiopulmonary bypass, prothrombin time and fibrinogen level measured by autoanalyzer (Stago -STA Compact Max). Bleeding time measured by the blotting paper and clotting time by the glass pipette.
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Materials and Methods
Statistical analysis
Statistical analyses were carried out using the Statistical Package for Social Sciences (SPSS) software and results were presented in tables.
Results
Total 60% of the patients belonged to the age above 50 years in Group A. The mean age was found 51.5 ± 4.7 years in Group A, 33.2 ± 10.2 years in Group B and 34.2 ± 11.4 years in Group C. The majority of patients were male and the difference of age was statistically significant (p<0.05) among the three groups. The difference of post-operative mean hemoglobin and RBC value on arrival at the intensive care unit, at 48 hours and at 7 days after surgery were statistically significant (p<0.05) among the three groups. The difference of post-operative mean total count of WBC and platelet were also statistically significant. The mean blood loss was 650.0 ± 280.7 mL in Group A, 683.5 ± 274.3 mL in Group B and 1513.3 ± 307.9 in Group C. Moreover, the difference of mean blood transfused was statistically significant (p<0.05) among the three groups (Table I) .
In this study, the mean cross-clamp time was statistically significant between the two sub-groups Group B and C. The mean total bypass was found 64.2 ± 16.9 min in Group B and 204.1 ± 85.6 min in Group C, which was also statistically significant (Table II) .
Discussion
In this study, it was observed that the majority of study patients in Group A were male and the age difference was statistically significant (p<0.05) among the three groups. Group A includes mostly ischemic heart diseases patients and we do prefer coronary artery bypass without using cardiopulmonary bypass. The difference of post-operative mean hemoglobin level and RBC value on arrival at Intensive Care Unit, at 48 hours and at 7 days after surgery were statistically significant (p<0.05) among the three groups. Moreover, post-operative mean total count of WBC and platelet were also statistically significant. The mean total bypass time and cross-clamp time were statistically significant (p<0.05) between the study groups. However, coagulation profile like mean fibrinogen level, bleeding time, clotting time and prothrombin time were statistically significant.
There is scanty of literature where we have compared irrespective of age and sex for this study. However, Roy et al. (2014) found that male was 77.4% in OPCAB group and 69.0% in cardiopulmonary bypass group, which is also discordance to this study. 10 Roy et al. (2014) observed that the mean age was 61.7 ± 7.3 years in OPCAB group and 60.2 ± 6.9 years in cardiopulmonary bypass group and the difference was not statistically significant, 10 which is also supported by Scrascia et al. (2013) who observed that the mean age was 65.1 ± 9.5 years in OPCAB (off pump coronary artery bypass) group and 66.8 ± 8.2 years in cardiopulmonary bypass group in their study. 12 This dissimilarity of present study may be due to involvement of miscellaneous type of patients including cardiopulmonary bypass group whereas in their study they include only CABG patients. 6, 8, 10, 13
In a study, Ascione et al. (2001) found hemoglobin level decreased more over time in the on-pump group despite this group requiring a significantly higher transfusion of red blood cells during the postoperative period. 13 The findings are consistent with other authors. 10, 14, 15 Mohnle et al. (2005) demonstrate that changes like decreased platelet counts, rise in white blood cell count mainly because of increased neutrophils, and fall in hemoglobin and hematocrit levels, which is concordance to this study findings. 14 Moreover, Moller and Steinbruchel (2003) demonstrated an increase in platelet activation after OPCAB and a temporary platelet dysfunction in the cardiopulmonary bypass group, which is also supported in several published literatures. 5, 10, 12, 15, 16 A limitation of this study was that we did not measure the platelet functions. In another study, Holloway et al. (1988) found that the decrease in platelet count during cardiopulmonary bypass was due to hemodilution for priming the extracorporeal circuit. 16 Several authors also found that platelet count in the on-pump group show the typical time course previously reported during and after operations with cardiopulmonary bypass. 13, 17
The greater reduction of platelet count throughout the study observed in the on-pump group suggests a depletion caused by contact activation with extracorporeal surfaces, bubble oxygenator, cardiotomy suction, and filters by Weerasinghe and Taylor (1998) . 18 However, the decrease of platelet count in the on-pump group was rarely less than the value (50,000-100,000/μL) normally required for hemostasis, suggesting a degree of impaired platelet function resulting bleeding after cardiopulmonary bypass. group. These data differ from those of larger trials, in which bleeding time in OPCAB group was lower compared to cardiopulmonary bypass group which is similar to this study. 20 In another study, Puskas et al. (2003) found a significant reduction of postoperative bleeding time in OPCAB group when compared to on-pump group which is similar to other study findings. 10, 15, 21, 22 Weerasinghe and Taylor (1998) found that thrombocytopenia and its relation to post-operative bleeding are well documented in association with cardiopulmonary bypass. 18 In a study, Kumle et al. (2003) found the mean aortic-cross-clamp-time was 64 ± 30 min which correspond to other studies.
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The decline in the blood hemoglobin level at the end of the operation in the off-pump group might be related to intraoperative blood loss. However, the effects of hemodilution have to be considered because the infusion of colloid or crystalloid solutions is required during off-pump coronary operations to maintain the mean systemic pressure at greater than 60 mm Hg, particularly during the distal anastomoses.
Conclusion
Cardiopulmonary bypass assisted cardiac surgery is associated with hemostatic abnormalities, but shorter cardiopulmonary bypass time minimizes this complication.
